Skip to main content
. 2022 Sep 2;106(10):2085–2091. doi: 10.1097/TP.0000000000004277

TABLE 2.

Antibody specificity

Antibody specificity Patients with DSA (n = 14) Patients with non-DSA (n = 11) P Value
Anti-HLA Class I 1 (7%) 5 (45%) 0.06
Anti-HLA DR 3 (21%) 6 (55%) 0.13
Anti-HLA DQ 10 (71%) 1 (9%) 0.001
Anti-S 9 (64%) 11 (100%) 0.16
Anti-S1 7 (50%) 7 (64%) 1
Anti-RBD 7 (50%) 11 (100%) 0.03
Anti-S2 6 (43%) 9 (82%) 0.13
Anti-NC 13 (93%) 6 (55%) 0.02

DSA, donor-specific anti-HLA antibody; S, trimeric spike protein; RBD, receptor binding domain; NC, nucleocapsid.